Literature DB >> 17062948

[Angiogenic effect of bone marrow mesenchymal stem cells transfected with human VEGF gene on myocardial infarcts in rats].

Wen-wu Zhou1, Jian-guo Hu, Jin-fu Yang, Ling Lin, Xin-min Zhou, Tao Tang.   

Abstract

OBJECTIVE: To evaluate the angiogenic effect of the bone marrow mesenchymal stem cells (MSCs) transfected with human vascular endothelial growth factor (VEGF(165)) gene on myocardial infarcts in rats.
METHODS: The animal model of heart ischemic was established by ligating the left anterior descending coronary artery in Wistar rats. The ligated rats were divided into 4 groups (n=12 each), and 2 weeks later they were injected hVEGF-transfected MSC at the heart infarct zone (Group A), MSC (Group B), liposome-hVEGF gene plasmid (Group C), and medium (Group D). Four weeks after the injection, the capillary density of the infracted zone and the expression of human VEGF in vivo were examined.
RESULTS: Four weeks after the transplantation,the capillary density was significantly greater in Group A than that in Group B and Group D, slightly greater than that in Group C. The highest expression of hVEGF was Group A, and followed by Group C, Group B, and Group D.
CONCLUSION: MSC is helpful for the stable expression of hVEGF gene, and is an ideal cellular vehicle for VEGF genes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17062948

Source DB:  PubMed          Journal:  Zhong Nan Da Xue Xue Bao Yi Xue Ban        ISSN: 1672-7347


  1 in total

1.  Effects of bone morphogenetic protein-2 (BMP-2) and vascular endothelial growth factor (VEGF) release from polylactide-poly (ethylene glycol)-polylactide (PELA) microcapsule-based scaffolds on bone.

Authors:  Q Ren; M Cai; K Zhang; W Ren; Z Su; T Yang; T Sun; J Wang
Journal:  Braz J Med Biol Res       Date:  2017-11-30       Impact factor: 2.590

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.